Close this search box.

Fragment-based approach applied to the discovery of protein-protein interactions stabilisers

Dario Valenti, Stanimira Hristeva, Christian Ottmann, Anna Karawajczyk



Protein-protein interactions (PPIs) are constituents of numerous biological pathways and offer therapeutic intervention points into different pathologies such as cancer1, inflammation2, neurodegenerative3 and metabolic diseases4. Particularly, stabilisation of complexes showed to play a key role in biological pathways offering an additional access point to their modulation. Since this approach has not yet been explored in a systematic way, the TASPPI (TArgeted small-molecule Stabilisation of Protein-Protein Interactions) consortium5 aims to identify chemical PPI stabilisers in order to develop new crucial therapeutic strategies in the treatment of the disease areas mentioned above.

Want to know more about this publication?
Contact our scientists

Medicinal chemistry

Drug Discovery

Taros’ international and multidisciplinary team has more than 180 years of pharmaceutical R&D experience. Collectively as a team, we worked on more than 120 biomolecular…

custom chemical services

Custom Synthesis

We support our customers by providing first kg quantities of fine and specialty chemicals, cost reduction of existing syntheses, streamlining chemical processes considering…

Looks interesting?

As a leading CRO in Europe, Taros provides comprehensive drug discovery chemistry services for large Pharma and Biotech corporations as well as for Research Institutes and Academia

Our experienced chemists practice a pragmatic culture and customer-centric approach in order to exceed project expectations and, despite challenges, bridge very narrow timelines. They are trained to consider economic, safety and ecological boundaries and conditions laid out for all stages of the project.
Scroll to Top